Non-Invasive Diagnosis of Fetal Anemia - SD
Introduction
My name is John Carlo Murray.
I am originally from Italy.
I've been in United States for more than 20 years now,
and I am an obstetrician, and my title is Professor
and Chair of OBS
and Gynecology at University of Tennessee in Memphis.
Today I will talk about fetal anemia
and how we can use ultrasound
to diagnose fetal anemia.
And I will tell you a little bit about the history,
how we came to diagnose fetal anemia.
Just with ultrasound.
Definition and Causes of Fetal Anemia
Fetal anemia is defined as an hemoglobin value
below the fifth percentile for gestational age.
There are many causes of fetal anemia,
however, in the United States, one
of the most uncommon causes of fetal anemia remains
red blood cell immunization.
Despite the use of rga,
which was introduced in 1968 in North America,
it today, it is estimated that there are approximately
4,000 cases of fetal anemia due to outreach,
hemolytic disease.
However, the RH is not the only cause of
red cell immunization
because there are many other antigens,
the so-called irregular antigens,
which may cause fetal anemia.
Think about K kid and others.
All immunization from irregular antigens cannot be prevented
by prophylactic administration of immunoglobulin
because they have not been developed
Historical Background
In 1941, Steiner
discovered the RH antigen.
It was approximately 10 years later that, Bevis
reported that the spectro automatic analysis
of the amniotic fluid could be useful in the antepartum
management of hemolytic disease of the neonate.
In 1956, Albert William Malali
performed his force amniocentesis.
In 1961, he reported
the Delta D 450 curve,
and two years later, he also reported his first
intraperitoneal fetal transfusion.
It was one year later in 1964
that Vincent Frida
performed the first intravascular transfusion
on a fetus anemic Aus at 26
weeks gestation.
What, Vincent Frida did is he performed the laparotomy
and his ster otomy.
He externalized one of the lower extremities
of the fetus, and he transfused the fetus
through the f femoral artery.
The procedure was successful,
but unfortunately the fetus died within 24 hours
from the transfusion.
However, two years later in Puerto Rico, Adamson performed
the first successful intravascular transfusion
on Anomic fetus
in 1968.
Thanks to the studies performed by Vincent Fried,
the RGA was introduced in North America, also, thank
to the help of the sinking prisoners
who helped for the study.
It was in early seventies that Carlo Valante,
an Italian who was working in New York at that time,
reported that Oscopy could be used
to diagnose open spina bifida
and to perform also fetal blood sampling.
After that, Charles Roddick in Europe and John Hobb
and Jeremiah Mahoney in the United States started to use
Oscopy to perform intravascular transfusion on Anomic Fe.
It was, in 1983 that Fernanda Dafo
reported described the technique for cord blood sampling,
under ultrasound guidance.
After this study, a period, the type defined
of anarchy started in fetal medicine
because many investigators all around the world started
to perform cord blood sampling,
and unfortunately, many times the procedure was unnecessary.
Limitations of Invasive Procedures
For many years, amniocentesis
and cordocentesis have been used
to diagnose fetal anemia.
However, both procedures are invasive.
Amniocentesis is invasive. It is not reliable.
Before 27 weeks gestation, we do not know what is the
optimal frequency of repeated sampling.
For example, if we do an amniocentesis
and the delta D 450 is in a safe zone,
we don't know when to repeat the procedure.
In a week, in two weeks, in four weeks, nobody really knows.
In addition, amniocentesis does not appear
to be reliable in kale sensitization
because with the kale,
the problem is not the hemolysis.
But the problem is the suppression of the
OID precursors at the level of the liver, spleen,
bone marrow, et cetera,
and am synthesis can also be associated with worsening
of maternal all immunization.
And here it is reported the L graph
with the three typical zones, one, two, and three.
And, and as you know, the l graph
with the L graph, we measure indirectly the bilirubin in
the amniotic fluid.
Therefore, if there is hemolysis, the bilirubin will
increase and also the value
reported here on the curve will increase.
Now, if the value is in zone one, the PHUs is non anemic.
If it is in zone two, the fetus is probably non anemic,
but is maybe becoming anemic.
And if the value is in zary,
the fetus is most likely anemic.
The green dots here represent the values
of the delta D 450 on a
fields who was anemic during
gestation, and he was an automic birth.
However, his mom underwent six amniocentesis,
so therefore six unnecessary procedures.
Now, the what about the cordocentesis?
A cordocentesis is more invasive than amniocentesis.
We do not know what is the optimal frequency
of repeated sampling,
and the cordocentesis may also be associated with worsening
of maternal immunization.
In addition, risks of cordocentesis are infections,
fetal bleeding, bradycardia, p om, and fetal demise.
Ultrasound Approaches to Diagnosis
For many years, investigators have tried to use ultrasound
to determine if the fetus was or not.
One of the parameters that was suggested was the diameter
of the umbilical vein.
Other investigators like
and have, suggested the use
of the spleen circumference.
Others like Alistair Roberts
and was suggested
as suggested the liver measurement,
the circumference of the liver.
Others like RAF
and Nicolini suggested
to look at the ascites.
At the end of the eighties, we came up with a hypothesis
and we said, if the phy is anemic,
the blood viscosity decreases
and the cardiac output probably increases.
The consequence of these two effects is
that the blood velocity must increase.
Doppler Ultrasound Concepts
And before I continue, I would like
to give you a few concepts in the optical ultrasound.
And in this slide, it is represented the relationship
between the, the cosign of an angle
and its value.
And as you can see, if the cosine of an angle becomes,
greater than zero degrees,
the value becomes smaller than one.
Therefore, when we want to obtain the blood velocity,
we need to make sure that the angle
between the ultrasound beam
and the direction of the blood flow is very close
to zero degrees, because if the angle is greater,
we will underestimate the velocity
because of the, the value.
As you can see, we will decrease.
Now with our machines,
we can either underestimate the blood velocity
or we can also overestimate the blood velocity
when we use an angle corrector.
In practical terms, it is not always easy to get an angle
of zero degrees, and that is the reason why
when we do doppler ultrasound, the fetus,
often we use indices which are angle independent.
Now, if the, blood velocity is direct
or is directed over the transducer, the waveforms,
the dopper waveforms will be represented above the baseline.
Whereas if the blood flow is directed away from the
transducer, the waveforms will be represented
below the baseline.
Here you can see the color doppler of the circular willis,
and the color red
and blue indicate the blood, the direction
of the blood flow.
Red here indicates
that the blood flow was directed toward the transducer,
and the blue indicates
that the blood flow in this case was directed away
from the transducer.
Here you can see flow velocity away from
of the middle cerebral artery.
To the question is the blood velocity in systole
actually is the PTO velocity, which is the highest point
of the waveform, which is in this case is s equal
to 56 centimeters per second.
And is this the real velocity of the blood flow in,
which it was obtained?
The answer would be probably yes,
because the angle between the ultrasound beam
and the blood flow, as you can see here,
the middles artery in red are very close to zero degrees,
and therefore these 56 centimeter per second is
the velocity of the blood flow.
Middle Cerebral Artery Peak Systolic Velocity (MCA-PSV) Technique
Here you can see the steps that we have described
at the beginning of the nineties,
but we did another study,
at two different institutions with Dr.
Abad in, six, seven years ago.
And these are the steps that we should use
when we want to measure the real blood velocity at the level
of the middle cerebral artery.
As you can see though, the, these are,
these steps are clearly defined,
but the most important concept is
that the middle cerebral artery should be imaged with
for its entire length as he reported,
and the wave from should be all similar to each other.
This is a small video clip.
It is an old video clip which shows the steps
that are needed to correctly sample the
middle cerebral artery.
Here you can see the circular Willis.
Here, there is the middle cerebral artery,
and as you can see, the middle cerebral artery is visualized
for its entire length,
and the sample volume is a place very close to the origin
of this vessel from the internal carotid artery,
and the wave from so should be all similar to each other.
Usually when I look at the blood velocity at the level
of the middle cerebral artery,
I repeat this at least three times.
When I see that I get a consistent value, I consider that
as the real value of the blood velocity.
Here you can see flow velocity wave from,
so the middle S artery with advancing gestation,
and here you can see the reference range
of the middle cerebral artery, peak systolic velocity
with advanced in gestation.
And the the green lines of, of course,
represent the reference range, whereas the, the yellow dots
represent the values from which the,
the reference range was obtained
In, in 1919.
In 1990, we did the study
and we, in this study we went
to look at the middle S artery peak systolic velocity
in s who were anemic cordocentesis,
and we plotted the values above the reference range.
And what we saw is that in many cases,
the blood velocity was above the upper limit of normal.
However, there were many other cases in which the blood
velocity was within the reference range.
We were a little bit disappointed when we saw this data.
However, we said the middle ceal artery peak historic
velocity as measured
by do ultrasound is increased in anemic osis,
and unnecessary procedures can be avoided.
There was something that we were missing,
and what we were missing, was the relationship
between the hemoglobin
and here is reported as a multiple sodo median
and the middle cerebral artery peak systolic velocity
reported as a multiple sodo median.
There was one of my former fellows, Ugo Oz,
who was a study with the midis,
and I remember that when I saw, when Ugo show me this graph,
I think that we realized what we had missed for a long time.
The concept is that if the pH is mildly
the middle cerebral artery,
p systolic velocity will not change much.
However, if the phy becomes anemic,
the blood velocity increases
and there is almost a linear correlation
between the velocity and the hemoglobin.
With this in mind, we organized a multicenter study,
which was conducted in
at eight different medical centers from all
around the world, and the first step was toan,
the reference range of fetal hemoglobin
with advanced ing gestation.
And here you can see the reference range
of the fetal hemoglobin.
The green dots represent the values
of from which the reference range was ofan,
and all these values were ofan.
At cordocentesis.
We also defined the anemia as mild, moderate, and severe.
After that, we went to plot the hemoglobin values
of obtained in 111 FES who underwent a cordocentesis
because based on traditional criteria, they were defined
to be severe anomic.
And what we found is this, first of all, we realized
that approximately 70% of the fetuses were,
had the hemoglobin value either in the normal range
or they were mildly.
And among the fetuses who had moderate to severe anemia,
30 40%
of them were hydro the red dots at the
time of the procedure.
Therefore, we were performing more than under procedure in
reality to detect to approximately to 20 fetuses.
And we were doing a lot of unnecessary procedures,
and the many fis were dying
because of an unnecessary procedure.
We also looked at the mids artery systolic velocity in the
old fes, and by using the cutoff of one point 50
multiple, so median, which was obtained to the
ROC receiver operating characteristic curve, we realized
that if we had the use of this cutoff,
we would have detected all the an osis
and we would have avoided approximately 70%
of the procedures.
In this study, we said the conclusion was
that the sensitivity
of the middles artery pick systolic velocity for detection
of significant fetal anemia is approximately a hundred
percent at to 12% false positive rate.
We also have found that in Cal immunization, the correlation
between mids artery peak systolic velocity
and hemoglobin is good.
And this is the curve
that we have used since we did our study,
11 years ago, where you have the median
and the one point 50 multiple solid median
you have on the y on the Y axis, the mids artery,
p systolic velocity,
and on the X axis gestational aging weeks
after that, there were many, investigators that said
that this is a good study,
but in a certain way, this is a retrospective study
because you have not used the middle cerebral artery to,
for time in a cordocentesis.
So, with this in mind, we organized another study.
Actually this was organized by Roland Zimmerman, one
of my friend who is a friend who is now chairman
of O-B-G-Y-N at the University of Zurich in Switzerland.
In this study, there were five tertiary referral centers.
There were 125 fetuses at risk for anemia,
and the middle ceal artery, p systolic velocity was used
for time in Cordocentesis.
In this study, we did not do a cordocentesis In 90
feis, we performed the 35 cordocentesis somewhere
unnecessary, and we missed two cases of anemia.
However, the interval between the last exam
and the, delivery, oh, and
and delivery was greater than three weeks.
Clinical Application and Follow-up
Up to now we have talked about the middles artery,
p systolic velocity that, can tell us if the PHUs has
or not significant anemia.
However, if we look at one value, when do we need
to repeat the another value?
If, for example, if FE is not anemic, do we need
to repeat the study in one week or maybe three weeks?
And this is the reason why we did another study.
We went to look at those
at the middle cerebral artery in Feis at risk
for anemia in fess who were not at risk for anemia.
We developed, we followed these feis longitudinally,
and here you can see the regression line of individual fess,
non anemic.
The black lines and the S regression lines of
DUIs became severely anemic.
As you can see, the slope of the two
of the curves is different.
Even when we went
to look at the phys were mild anemic at cordocentesis,
we found that the slope between the,
normal non anemic osis in Blake
and the mildly anemic fibrosis was different.
Okay, so we developed this graph based on this graph.
We repeat the scan between one and four weeks.
What we do today is this, if the the values,
we will obtain the mid cerebral artery,
peak systolic velocity in fis who are at risk for anemia.
At the week apart, we will obtain three values, and
after that we look at the, the regression line.
If the regression line is to the right of this green
dotted line, we repeat the scan between two and four weeks.
For example, if the patient is at 20 weeks gestation
with no history of a previous fetal, anemia,
and she has a title
of anti D 1 64 1 over 28,
and the regression line is to the right of this green
dotted line, we repeat the scan in a month.
We don't bring the patient back in a week or two weeks
because it is not necessary, whereas it is between the green
and the yellow red line.
We repeat the scan usually in one week,
and if it is to the left of the red line
and the middles artery, p systolic velocity is still
below the one point 50 multiple.
So the median, we repeated the scan in two
or three days to see if we can confirm the values or not.
Today, we are more rarely using this graph
because we just look at the trend
and by looking at the trend, I will say that
for the last probably eight
or 10 years, we have not missed any anemic
or severely anemic PHUs,
and we did not perform any unnecessary procedures.
There are many studies which have confirmed
that fetal anemia is a good tool for to use.
I'm sorry that the middle sal artery,
peak systolic velocity is a good tool, good to look
for fetal anemia.
Patient Selection and Technique Considerations
But I would like to ask some questions.
Which patients are candidates for the assessment
of the middle sal artery peak systolic velocity?
First of all, patients should be at risk for having an fetus
because if the fetus is not a risk, there is no reason
to look at the peak systolic velocity.
Where do we need to sample the middle sal artery?
Peak systolic velocity?
And we have learned that
by sampling the middle cerebral artery,
peak systolic velocity, soon
after its origin from the carotid, there is the lowest
intra and inter observer error.
How do sonographers systemologies achieve a good training?
Well, first of all, sonographers,
ologists should become familiar with the steps
for the middle cerebral artery,
p systolic velocity assessment,
and at least at the beginning,
they should contact the centers for advice.
Of course, centers with experience
is the delta D 450 better than a mid cere artery,
peak systolic velocity, or vice versa.
In 1997, we reported
that the middle cerebral art peak systolic velocity was at
least as good as the delta D 450.
This is this data were confirmed by, Perera
and by opus.
Actually, opus was the leader order of the,
for the diamond study group.
This study went to compare doppler
of the middles artery, peak systolic velocity versus
amniocentesis to predict fetal anemia.
And the study showed that the doppler of the mids artery,
peak systolic velocity performed a better in terms
of sensitivity, specificity, positive
and negative predictive value when compared
to the the amniocentesis.
And this I think was a really a great study.
Now, based on this to the question,
is the middle cerebral artery, p systolic velocity standard
of care for the diagnosis of fetal anemia?
I think that today the answer probably can be yes, it is,
it is at least in the United States,
and I will say many areas of the world has become
the standard of care.
Now, it is also true that people can, some people,
some investigators continue to do amniocentesis,
but I think that it would be very important today
to tell the patient that there is, if somebody wants
to do an amniocentesis, the patient should be informed at,
told that there is a test that is less
invasive than amniocentesis
and it is better than the amniocentesis.
And after that, the patient, of course,
can make the, can choose.
And I think this will be important to, to talk
to the patient because of, of legal issues
that could arise in the future.
Today also the American College of of o ob, GYN
as recognized the middle civil artery pick systolic velocity
as a good parameter to use in cases of fetal is at risk
for fetal anemia.
And what is to be the management algorithm
of fetal anemia today?
I think that it is synthesized here, the only,
and this can be found on many textbooks.
The only difference with the,
what is found still in some textbooks is that instead
of amniocentesis
or cordocentesis, we should report middle S artery.
Peak systolic velocity.
Sequential studies is the middle S artery peak systolic
velocity reliable in s previously transfused,
there is a study that is going on now organized by
Greg Ryan, and, he's a group in Toronto
and with, Nelson
and other fellows all around the world,
a problem will get an answer in,
four
or five years about this.
Although I think that today the most important concept is
that the artery pick systolic velocity is important to,
to diagnose anemia at the beginning, because
after that, I think that will be, in a certain way,
it's easy to manage anony failures
after that has been transfused.
Is the artery peak systolic velocity reliable
for the diagnosis of fetal anemia due to other causes?
And the answer is yes.
There are many, many studies now in the literature which
have reported that the mids artery
peaks historic velocity is useful in cases
of parvovirus infection, feto, maternal hemorrhage,
non-immune eyedrops in cases
of monoclonic twins following the death of the co twin
and in cases of twin twin transfusion syndrome
following the laser therapy.
Clinical Examples
I would like now to show you some examples to see
how we are using the middle S artery peak systolic today.
By doing in this way, as I said
before, we have not missed any case of severe anemic anemia.
I will say probably for more than 10 years now,
and we have not performed any unnecessary procedure based on
the CE artery historic velocity.
Case Number One
This is a case number one.
The patient was a 33-year-old, the gravitate three,
with an anti DO one over 64,
and she had an increased delta D 450 in the amniotic fluid.
The fetus was a reached positive,
and she underwent a cordocentesis at 22 weeks,
but this was unsuccessful.
The patient was referred
to our group at 22 weeks in one day,
and this was the Delta D 450
that had been done previously by another group.
And when she came to see us,
we gave her several option Tri cordocentesis, again, wait
for signs of eye drops
or look at the middle cerebral artery,
peak systolic velocity assessment.
She opted for the middle cerebral artery,
peak systolic velocity,
and the first value was below one point 50 M.
And after a month, approximately three month,
the value became, above one point 50 MOM.
At that point, we did a cordocentesis,
and the OZ anemic was 7.4 grams per
deciliter, the hemoglobin.
And here you can see the, the, the trend of the MSCA
of the mids artery peak historic velocity Following the
transfusions, as you can see,
after transfusion, the value drops decreases.
Another Case: Kell Sensitization
This another case, the patient was cal sensitized.
The unical titer was one of 512.
The PHUs because of an amniocentesis was K positive,
and the patient opted
for middle s artery systolic velocity assessment.
The first value was very close to one point 50 MOM,
but in a couple of weeks this value,
there was a sharp increase over the value.
We did the cordocentesis
and the, the hemato was 17%.
The patient, the baby was transfused, went to 31%.
The velocity decreased, and after increased again and
after decreased again after the cordocentesis.
Case Number Three
Case number three, this was a case of,
anti dfi and the value went from 1 28
to 1 0 512.
We started to follow the patient
with mid ceal artery peak historic velocity,
and the values were all below
the one point 50 multiple of media.
However, the title went to one oh 1024.
I think we continue to follow the patient with ceal artery.
We did not to do any procedures at that point,
although we became very nervous because of this value.
But the baby delivered a term.
And when the value was repeated in the ma,
it was one over 256
and the baby was an, an birth actually was 41%.
Case of Decreased Fetal Movements
The patient was a 28-year-old primi gra at 36 weeks
gestation with a decreased of fetal moments.
She had been seen in the office,
in the private office the day before,
and the NST was reported, was reactive.
She came back to the hospital day, the day
after, again, with decreased fetal movements.
Here you can see the, the typical cidal pattern,
but also we looked at the middle S artery,
peak systolic velocity,
and the value was 1 110 centimeters per second,
well above the, the one point 50 M om.
Anyway, the patient was delivered by C-section.
The hemato was seven percent.
Anyway, the baby was transfused and did well.
Conclusion
In conclusion, the middle cerebral artery systolic velocity
is an excellent tool for the diagnosis of a fetal anemia.
Many babies today will live an healthy life
because of a middle cerebral artery, p systolic velocity.
It is important to emphasize that the training
of sonographers and the sonologist is indispensable.
And thank you.
Related Videos
Upper Limb Arterial Doppler - Part 1
Nitin Chaubal, MD
Fetal Gastrointestinal System
Mary C. Frates, MD
Ultrasound Guided Abdominal Biopsies: Lessons Learned - Part 2
Michael Hill, MD
Ultrasound Guided Abdominal Biopsies: Lessons Learned - Part 3
Michael Hill, MD
Fetal Gastrointestinal System
Mary C. Frates, MD
Fetal Gastrointestinal System
Mary C. Frates, MD
Important Disclaimer
No continuing medical education (CME) credit is offered or implied by participation in or viewing of the Sonoworld Legacy Archive. The content is provided for informational and historical purposes only.
Some material may be out of date and should not be used as a basis for medical decision-making, diagnosis, or patient care. IAME does not warrant the accuracy or completeness of information provided in these videos.
Users are urged to consult qualified medical professionals and up-to-date resources for current standards of care.
Connect with Us!
Feel free to reach out to us for further information!
IAME is accredited by ACCME to provide AMA PRA Category 1 Credit™ for physicians and healthcare professionals.
We operate in North America, Australia, and South Korea.
© 2026 Institute for Advanced Medical Education, All Rights Reserved.

